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Edited by Michael R. BubbAbstract TPPP/p25, a ﬂexible unstructured protein, binds to
tubulin and induces aberrant microtubule assemblies. We
identiﬁed hereby glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as a new interacting partner of TPPP/p25. The immu-
noprecipitation and aﬃnity chromatographic experiments with
bovine brain cell-free extract revealed that the interaction was salt
and NAD+ sensitive while ELISA showed resistant and ﬁrm asso-
ciation of the two isolated proteins. In transfected HeLa cells at
low expression level of EGFP-TPPP/p25, while the green fusion
protein aligned at the microtubular network, GAPDH distributed
uniformly in the cytosol. However, at high expression level,
GAPDH co-localized with TPPP/p25 in the aggresome-like
aggregate. Immunohistochemistry showed enrichment of TPPP/
p25 and GAPDH within the a-synuclein positive Lewy body.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The search of protein–protein interactions becomes a more
and more important issue for understanding the multiple func-
tions of the gene products in the post-genomic era. Recently,
we have isolated a new brain-speciﬁc protein from bovine
brain tissue and denoted it to TPPP/p25 protein reﬂecting its
function (Tubulin Polymerization Promoting Protein) as
well as its molecular mass (25 kDa) [1,2]. This bovine proteinAbbreviations: DAPI, 4 0,6-diamidino-2-phenylindole; DHB, 2,5-dihy-
droxybenzoic acid; DTE, 1,4-dithioerythritol; DTT, 1,4-dithiothreitol;
FCS, fetal calf serum; GAPDH (EC 1.2.1.12), glyceraldehyde-3-pho-
sphate dehydrogenase; IAM, iodoacetamide; LB, Lewy body; MAL-
DI-TOF, matrix-assisted laser-desorption ionization time-of-ﬂight;
MT, microtubule; PD, Parkinson’s disease; PSD, post source decay;
TMRE, tetramethylrhodamine ethyl ester
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doi:10.1016/j.febslet.2006.09.037showed high homology with p25a, a human gene transcript
[3]. We have shown that TPPP/p25 is a heat stable cationic
intrinsically unstructured protein [1,4], which displays struc-
tural similarity to a-synuclein [4]. TPPP/p25 interacts with
tubulin, induces aberrant tubulin assemblies and bundling of
microtubules (MTs) both in vitro and in vivo systems [1,5].
We have proved that TPPP/p25 extensively co-localizes with
the microtubular system in transfected HeLa cells and at high
expression level it causes the formation of aggresome-like body
at the centrosome region [5]. Our data on pathological brain
tissues have revealed that TPPP/p25 co-localizes with a-synuc-
lein in cytosolic inclusions in the case of Parkinson’s disease
(PD) and other synucleinopathies [6]. We have suggested that
the formation of protein aggregates in HeLa cells induced by
the over-expression of TPPP/p25 could be related to a patho-
logical process leading to neurodegeneration [5].
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
considered as a classical glycolytic housekeeping enzyme with
its glycolytic activity. Nowadays, more and more evidence
have been accumulated which suggest that GAPDH displays
a number of additional activities due to its multiple interac-
tions with diﬀerent cytosolic and nuclear proteins, nucleic
acids and subcellular particles ([7] and references therein).
GAPDH has a general mediator role in the initiation of apop-
totic cascades [8], and interacts with diﬀerent proteins involved
in age-related neurodegenerative disorders such as Hunting-
ton’s disease, Alzheimer’s disease and ataxias [9]. It has been
recently shown that the over-expression of both GAPDH
and a-synuclein in COS-7 cells induced Lewy body (LB)-like
cytoplasmic inclusions [8]. In fact, it has been suggested that
a-synuclein itself is not suﬃcient to cause aggregation into
LB-like inclusions, but additional factors such as oxidative
stress, mitochondrial dysfunction and macromolecular interac-
tions probably play role in the pathogenesis. For example,
GAPDH was found to be a stimulator of a-synuclein aggrega-
tion in PD. Recently, proteomic analysis suggested the co-
occurrence of TPPP/p25 and GAPDH in rodent brain postsy-
naptical density [10,11].
In this work we identiﬁed GAPDH as a potential interacting
partner of TPPP/p25. We demonstrated that these two pro-
teins interacted with each other in vitro, and co-localized inblished by Elsevier B.V. All rights reserved.
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ological brain tissue.2. Materials and methods
2.1. Materials
Dithiothreitol (DTT), iodoacetamide (IAM), ammonium bicarbon-
ate (NH4HCO3) and 2,5-dihydroxybenzoic acid (DHB) were obtained
from Sigma (Germany), the sequencing grade Modiﬁed Trypsin (mod-
iﬁed by reductive methylation) was ordered from Promega. Millipore
C18 ZipTip and prelubricated microcentrifuge tubes (washed with
HPLC grade methanol) were used. Monoclonal anti-a-tubulin anti-
body in mouse (DMA1) was purchased from Sigma.
Rabbit muscle GAPDH was Sigma product in ammonium sulphate.
The salt was removed from GAPDH solution by extensive dialysis
against PBS buﬀer containing 1 mM 1,4-dithioerythritol (DTE). The
ratio of OD280/OD260 of the GAPDH solution was 1.35 ± 0.05, which
corresponded to about 2 moles ﬁrmly bound NAD+ per mole tetra-
meric enzyme [12]. To obtain apo-GAPDH, the ﬁrmly bound NAD+
molecules were removed by using activated charcoal [13].2.2. Antibody production
Two diﬀerent anti-TPPP/p25 antisera were used in the experiments.
One of them was raised against a fragment of TPPP/p25 (186-200 res-
idues) as described previously [6]; the other antiserum was raised in rat
against human recombinant His6-tagged TPPP/p25. Antiserum raised
against rabbit muscle GAPDH was produced in rat. The protocols
used for immunization and testing the sera were similar to that de-
scribed earlier [6].
2.3. ELISA
The microtiter plate was coated with 5 lg/ml (100 ll/well)
apo-GAPDH or GAPDH containing 2 ﬁrmly bound NAD+ per tet-
rameric enzyme in PBS containing 1 mM DTE in the presence or in
absence of NAD+ overnight at 4 C. The wells were blocked with
0.5% BSA in PBS for 1 h at room temperature. Next, the plate was
incubated with serial dilutions of pure TPPP/p25 in the concentration
range between 2 lM and 0.0195 lM, in the presence and in absence of
NAD+ or 150 mM NaCl for 1 h at room temperature in PBS. Then the
plate was sequentially incubated with the anti-TPPP/p25 serum (dilu-
tion 1:2000), and with the anti-rat IgG-peroxidase conjugate (dilution
1:5000). Both antibodies were in PBS buﬀer containing 0.5% BSA, and
incubated for 1 h at room temperature. Between each incubation steps
the wells were washed three times with PBS. When the TPPP/p25 was
incubated with a buﬀer containing 10 mM NaCl, then the wash was
performed in the same condition (10 mM phosphate, 10 mM NaCl,
pH 7.4). o-Phenylenediamine in the concentration of 3.7 mM with
0.03% peroxide was used as substrate solution. The peroxidase cataly-
sed reaction was stopped after 15 min with 1 M H2SO4; absorbance
was read at 495 nm with a Wallace Victor 2 multiplate reader.
2.4. Preparation of cytosolic brain extract
Cytosolic extract was prepared from bovine brain tissue. The tissue
was homogenized in PEM buﬀer (50 mM PIPES pH 6.6, containing
1 mM EGTA, 5 mM MgCl2, 1 lg/ml leupeptin, 1 lg/ml pepstatin) at
a 1:1.5 ratio of tissue and buﬀer. The homogenate was centrifuged at
30000 · g at 4 C for 20 min, and then the supernatant was again centri-
fuged at 100000 · g at 4 C for 30 min. This supernatant of a25 mg/ml
total protein concentration was used as cytosolic bovine brain extract.
In some case the microtubular proteins were removed by assembling
the MTs with adding paclitaxel and GTP as described previously [14].
NAD+ content of the extract was determined by enzymatic assay using
excess GAPDH, glyceraldehyde-3-phosphate and arsenate.
2.5. Aﬃnity chromatography
TPPP/p25 was immobilized to CNBr-activated Sepharose 4B (Amer-
sham) according to the manufacturer’s instructions. The TPPP/p25
bound to Sepharose was packed into columns. The binding capacity
of a column was 3 mg TPPP/p25 per 1 ml Sepharose. The aﬃnity col-
umn was equilibrated with phosphate buﬀer (10 mM phosphate buﬀer
pH 7.0 containing 10 mM NaCl). The extracts (with or without micro-
tubular proteins) were loaded to the column, and the column waswashed with phosphate buﬀer. The bound proteins were eluted with
phosphate buﬀer plus 0.5 M or 150 mM NaCl. Typically, 2 ml
25 mg/ml extract was loaded to the column (1 ml) and the total
amount of the eluted protein was 500–800 lg. After each experiment
the column was regenerated using 3 cycles of 0.1 M Na-acetate pH 4.0
buﬀer containing 0.5 M NaCl and 0.1 M Tris pH 8.0 buﬀer containing
0.5 M NaCl. The eluted proteins were concentrated using an Amicon
ultraﬁltration stirred-cell apparatus ﬁtted with an YM-10 membrane,
followed by SDS/PAGE. Proteins were electrotransferred onto Immo-
bilon-PSQ transfer membranes. The ﬁlters were subjected to immuno-
blotting with an antiserum directed against rabbit muscle GAPDH
in rat (dilution 1:1000) or with an antibody directed against a-tubulin
in mouse (dilution 1:2500). Antibody binding was revealed by using
anti-rat (dilution 1:2500) or anti-mouse (dilution 1:2500) IgG coupled
with peroxidase, ECL (enhanced chemiluminescence) Western Blot-
ting Detection reagents (Amersham Biosciences) and Kodak X-Omat
AR ﬁlm.
2.6. Immunoprecipitation
The tubulin-free bovine brain extract (25 mg/ml, 50 ll) was incu-
bated with 4 ll serum raised against the human recombinant TPPP/
p25 protein in 50 mM Tris pH 8.0 buﬀer containing 25 mM NaCl
and 0.05% SDS (total volume of each sample was 100 ll). After over-
night incubation at 4 C, the samples were centrifuged at 15000 · g at
4 C for 10 min; the pellets were washed with 100 ll buﬀer, resuspended
in 20 ll Laemmli sample buﬀer, and then loaded to SDS/PAGE. The
same series of samples were further incubated for 2 h with Red Protein
G Aﬃnity Gel (Sigma). The respective beads were collected and were
washed three times with 500 ll buﬀer, the beads were resuspended in
20 ll Laemmli sample buﬀer, and then the samples were boiled. Immu-
noprecipitates were analysed by SDS/PAGE in each case.2.7. Mass spectrometry
SDS–PAGE puriﬁed proteins were reduced with DTT (10 mM
DTT, 25 mM NH4HCO3, 30 min, 56 C) and alkylated with IAM
(55 mM/25 mM NH4HCO3, 30 min, room temperature). This was fol-
lowed by digestion with trypsin (4 h, 37 C) and extraction of the pep-
tides. The digests were puriﬁed on C18 ZipTip and unfractionated
tryptic digests were analyzed on a Bruker Reﬂex III matrix-assisted la-
ser-desorption ionization time-of-ﬂight (MALDI-TOF) mass spec-
trometer in reﬂectron mode. DHB was used as the matrix. In the
MALDI-TOF mass measurements external calibration was used. Post
source decay (PSD) spectra were collected in 12–14 steps, lowering
reﬂector voltage by 25% in each step, and then stitching the data to-
gether. The peak lists were generated with X-Tof (version 5.1.5) soft-
ware. Mascot database search software (http://www.matrixscience.
com/) was used to identify the proteins in the full NCBI database
(2006.02.11, 3292813 sequences). Monoisotopic masses within
200 ppm mass accuracy were considered in the peptide mass ﬁnger-
print-search, while average mass fragment ions within ±1 kDa were
considered for the PSD data. Only tryptic peptides, with two missed
cleavages were permitted. Cys-carbamidomethylation was considered
as ﬁxed modiﬁcation, while a series of variable modiﬁcations, such
as pyroglutamic acid formation from N-terminal Gln residues, the oxi-
dation of methionine and the acetylation of protein N-termini were
also permitted. Protein scores greater than 78 were accepted as signif-
icant (P < 0.05).
2.8. DNA manipulations of TPPP/p25 coding sequence, cell culture and
transfection and live cell imaging
The coding region of human TPPP/p25 [6] was fused to the C termi-
nus of EGFP by cloning TPPP/p25 ORF into pEGFP-C1 (Clontech)
using the BglII and the EcoRI restriction sites (pEGFP-TPPP/p25)
as described previously [5]. HeLa (American Type Culture Collection,
CCL-2) cells were grown and transfected as described earlier [5]. For
immunoﬂuorescence studies, cells were grown on 12 mm round cover-
slips and transfected with 50 ng DNA, otherwise they were grown on
60 mm dishes. To characterize the mitochondrial membrane polariza-
tion in live experiments, tetramethylrhodamine ethyl ester (TMRE) up-
take was used [15]. Transfected cells were incubated with 50 nM
TMRE in complete medium for 20 min. Cells on coverslips were
washed with incubation medium (PBS supplemented with 50 nM
TMRE, 1 mM sodium pyruvate and 1 g/L glucose), then the coverslips
were placed on slides with cells upside. The cells were covered in incu-
Fig. 1A. SDS/PAGE analysis of interacting partners of TPPP/p25 by
immunoprecipitation. The pellet fraction was loaded to the SDS/
PAGE. Lane 1: molecular weight marker. Lane 2: serum against
TPPP/p25. Lane 3: bovine brain extract. Lanes 4 and 5: Brain extract
incubated with serum without and with exogenous recombinant TPPP/
J. Ola´h et al. / FEBS Letters 580 (2006) 5807–5814 5809bation medium with an extra coverslip, and were sealed with molten
agarose. Fluorescent images of live cells were recorded within 1 h on
temperated microscopic stage.
2.9. Immunocytochemistry
Transfected HeLa cells were ﬁxed with cold methanol for 12 min,
were rehydrated in PBS, and next were blocked for 60 min in PBS con-
taining 10% fetal calf serum (FCS) (FCS-PBS). Subsequently, cells
were stained with anti-GAPDH antibody overnight at 4 C, followed
by Texas-Red conjugated anti-rat antibody (Jackson Laboratories)
for 1 h at 25 C, all diluted in FCS-PBS. After washing in PBS, nuclei
were counterstained with 4 0,6-diamidino-2-phenylindole (DAPI) and
coverslips were mounted on Gel Mount Aqueous Mounting Medium
(Biomeda). Images were recorded on Leica DMLS microscope (Leica
Microsystems, Germany) equipped with cooled CCD camera (Spot,
Digital Instruments, USA), with C-PLAN 100· immersion objective.
The signal of EGFP was investigated by narrow band GFP ﬁlter set
(Chroma Technology Inc.). Texas-Red signal was detected with Leica
ﬁlter set N2.1 (illumination of samples was kept minimally in live
experiments). Spot 4.0.9 was used to acquire digital images. Analysis
of digital images was done with ImageJ (PC-based version of NIH
Image).p25. The band indicated by an arrow was cut from the gel and was
identiﬁed as GAPDH by mass spectrometry.2.10. Immunohistochemistry
Formalin ﬁxed paraﬃn-embedded tissue blocks from the mesen-
cephalon including the substantia nigra of one neuropathologically
conﬁrmed PD case (76-year-old woman) was obtained. Rat polyclonal
anti-GAPDH antibody (1:20), anti-TPPP/p25 (1:200), and anti-a-syn-
uclein (mouse monoclonal, 1:10000, Signet) after a pretreatment
including 10 min microwave in citrate buﬀer and 1 min 88% formic
acid were used. As a secondary system we used the Envisione detec-
tion kit (Dako, Glostrup, Denmark) including diaminobenzidine as
chromogenic substrate. As control the primary antibodies prior to
immunostaining were omitted. To evaluate double immunoﬂuorescent
labelling images were recorded on a ZEISS LSM 510 confocal laser
microscope. For GAPDH and TPPP/p25 rabbit anti-rat antibody
(1:200, Dako) was applied as intermediary incubation step. Hence
the ﬂuorescent labelled secondary antibody for GAPDH and
TPPPP/p25 was Alexa Fluor 633 goat anti-rabbit IgG (1:200, Molecu-
lar Probes, USA) and for a-synuclein Alexa Fluor 488 goat anti-mouse
IgG (1:200, Molecular Probes). Argon 488 nm and Helium/Neon
633 nm lasers were used to elicit immunoﬂuorescent signal.Fig. 1B. MALDI-TOF mass spectrum of the unfractionated tryptic
digest of Bos taurus GAPDH. 64% of the detected peptides matched
the sequence of the protein and 51.6% of the protein sequence covered
by these peptides. Matched sequence positions are shown in square
brackets, M(O) stands for methionine sulfoxide. DHB was used as
matrix.3. Results and discussion
3.1. TPPP/p25 interacts with GAPDH in bovine brain extract
The major objective of this work was to identify new inter-
acting protein(s) of TPPP/p25, a tubulin binding unstructured
protein [1], the physiological and/or pathological functions of
which are obscure. Two sets of experiments were performed:
immunoprecipitation and aﬃnity chromatography. Cell-free
extract from bovine brain was prepared for these experiments.
In some cases, microtubular proteins were removed from the
extract to abolish the possible competition of the new target
protein(s) and microtubular proteins for TPPP/p25 binding,
or exogenous recombinant TPPP/p25 was added to the extract
to enhance the amount of immunoprecipitate.
In these co-immunoprecipitation experiments, the brain ex-
tract was pre-incubated with anti-TPPP/p25 serum raised
against human recombinant TPPP/p25 protein. Fig. 1A shows
the SDS/PAGE images of control samples as well as those
of the immunoprecipitates. No pellet (protein) was obtained if
the extract or the antiserum was preincubated alone. However,
immunoprecipitate was formed when both the extract and the
speciﬁc antiserum were co-incubated. The SDS/PAGE analysis
of this fraction revealed the presence of some protein in the pre-
cipitate. In addition to the protein bands corresponding toTPPP/p25 and the heavy and light chains of IgG (60 and
23 kDa), a characteristic band of a protein with 35 kDa
was visible on the SDS/PAGE image, the intensity of which
was not enhanced by the addition of exogenous TPPP/p25
(Fig. 1A). This protein band was identiﬁed from a tryptic digest
by mass spectrometry. This band corresponds to Bos taurus
GAPDH (NCBI LOCUS: AAI02590, NP_001029206, P10096,
MW 36 kDa). 64% of the detected masses matched predicted
tryptic peptides of the protein and 51.6%of the protein sequence
was covered by these fragments (Fig. 1B). This identiﬁcationwas
conﬁrmed by MS/MS (PSD) analysis of MH+ = 1032.51 and
MH+ = 1763.62, that correspond to sequences VKVGV-
NGFGR [2–11] (Fig. 1C) and LISWYDNEFGYSNR [308–
321] (data not shown).
In the other set of experiments, TPPP/p25 aﬃnity column
was prepared as described in Section 2, and bovine brain ex-
tracts were loaded onto the aﬃnity column to isolate protein(s)
interacting with TPPP/p25. Fig. 2A shows the SDS/PAGE
Fig. 2B. Quantitative determination of GAPDH bound to TPPP/p25
aﬃnity column. Lanes 1 and 6: cytosolic and tubulin-free brain extract
loaded to the column, respectively. Lane 2: eluted fraction from the
mocked column. Lanes 3–5: eluted fractions, when cytosolic brain
extract was loaded in the presence of 0, 0.5 and 5 mMNAD+. Lanes 7–
9: eluted fractions, when cytosolic brain extract without tubulin was
loaded in the presence of 0, 0.5 and 5 mM NAD+. Lanes c1 and c2:
GAPDH (0.4 and 0.8 lg) as control. The same amounts of proteins
were loaded to the gel as in Fig. 2A.
Fig. 2C. Quantitative determination of tubulin bound to TPPP/p25
aﬃnity column. Lanes 1 and 6: cytosolic and tubulin-free brain extract
loaded to the column, respectively. Lane 2: eluted fraction from the
mocked column. Lanes 3–5: eluted fractions, when cytosolic brain
extract was loaded in the presence of 0, 0.5 and 5 mMNAD+. Lanes 7–
9: eluted fractions, when cytosolic brain extract without tubulin was
loaded in the presence of 0, 0.5 and 5 mM NAD+. Lanes c3–c5:
Tubulin (0.3, 0.6 and 0.9 lg) as control. The same amounts of proteins
were loaded to the gel as in Fig. 2A.
Fig. 2D. PSD-spectrum of MH+ = 1025.61 peptide, corresponding to
the IGGIGTVPVGR [256–266] sequence of Bos taurus elongation
factor 1 alpha. NH3 loss from certain peptide fragments is indicated by
asterisks.
Fig. 3. GAPDH–TPPP/p25 interaction followed by ELISA. The plate
was coated with either apo- (A280/A260 > 1.8) (h) or with holo-
GAPDH (A280/A260 < 1.5) (all other curves) (0.5 lg/well), and then
incubated with TPPP/p25 in absence (h, r, m) or in the presence (s)
of 5 mM NAD+. 150 mM NaCl was present in all experiments except
(r). The data points are average of four parallel experiments.
Fig. 2A. SDS/PAGE analysis of the proteins bound to the TPPP/p25
aﬃnity column. Lanes 1 and 6: Cytosolic and tubulin-free brain extract
loaded to the column, respectively. Lane 2: eluted fraction from the
mocked column. Lanes 3–5: eluted fractions, when cytosolic brain
extract was loaded in the presence of 0, 0.5 and 5 mMNAD+. Lanes 7–
9: eluted fractions, when cytosolic brain extract without tubulin was
loaded in the presence of 0, 0.5 and 5 mM NAD+. Lane c: Tubulin
(1.5 lg) and GAPDH (1.5 lg) as controls. In the case of loaded
samples 30 lg proteins were loaded to the gel, while in the cases of
eluted fractions 10 lg proteins.
Fig. 1C. PSD-spectrum of MH+ = 1032.67 peptide, corresponding to
the VKVGVNGFGR [2–11] sequence of Bos taurus GAPDH. NH3
loss from certain fragments is indicated by asterisks. Peptide fragments
are labelled according to [25].
5810 J. Ola´h et al. / FEBS Letters 580 (2006) 5807–5814images of the loaded extracts with or without endogenous
tubulin, the controls and the fractions retarded on the aﬃnity
column. In the bound fraction two intensive protein bands of50 kDa and 35 kDa can be visualized. As a control, a mocked
column (prepared using the same procedure, but without
bound TPPP/p25) did not retard any protein from the brain
extract. Western blotting using speciﬁc anti-tubulin antibody
J. Ola´h et al. / FEBS Letters 580 (2006) 5807–5814 5811or an antiserum raised against GAPDH provided evidence that
the 35 kDa and 50 kDa bands corresponded to GAPDH and
tubulin, respectively; and that the binding of GAPDH to the
immobilized TPPP/p25 was rather independent of the presence
of microtubular proteins in the loaded extract (Figs. 2B and
2C). The intensity of the 50 kDa protein band in the retarded
fraction signiﬁcantly decreased when tubulin-free extract was
loaded (cf. Fig. 2C). This faint band was identiﬁed as Bos tau-
rus elongation factor 1 alpha (NCBI LOCUS: CAB88863 MW
50 kDa) by mass spectrometry. 17% of the detected masses
matched predicted tryptic peptides of the protein and 17% of
the protein sequence was covered by these fragments. This
identiﬁcation was conﬁrmed by MS/MS analysis of MH+ =
1025.61 and MH+ = 1314.74, that correspond to sequences
IGGIGTVPVGR [256–266] (Fig. 2D) and EHALLAYT-
LGVK [135–146] (data not shown).Fig. 4. Localization of endogenous GAPDH in HeLa cells expressing EG
cytosolic distribution of GAPDH at low expression level (A–C) in contrast to
(D–F). Pictures (G–K) represent diﬀerent level of mitochondrial membrane
mitochondrium at low expression level of EGFP-TPPP/p25 (G–I) similar to
potential damage of the highly expressing cells (J–K).To test the nature of the interaction of TPPP/p25 with
GAPDH, similar sets of experiments were carried out on
TPPP/p25 aﬃnity column as described above, except that
NAD+ or salt was added to the extract. As shown in Fig. 2A,
at the addition of 0.5 mM NAD+ the binding of GAPDH to
the immobilized TPPP/p25 was reduced; at 5 mM NAD+ con-
centration virtually no GAPDH binding was detected. To test
the eﬀect of physiological salt concentration, the bound
GAPDH was eluted with 150 mM NaCl-containing buﬀer.
No signiﬁcant binding of GAPDH to the immobilized TPPP/
p25 from brain extract could be detected in these cases (data
not shown). These data, therefore, suggest that the association
of TPPP/p25 with GAPDH is NAD+ and ionic strength sensi-
tive. It should be added that the binding of tubulin to the TPPP/
p25 column was also salt sensitive, even if in less extent
than that of GAPDH. About 150 mM salt concentrationFP-TPPP/p25 at diﬀerent expression levels. Note the homogeneous
its aggregation within the aggresome-like body at high expression stage
polarization measured by TMRE uptake. Note the highly polarized
that of the untransfected cells (red only), in contrast to the membrane
5812 J. Ola´h et al. / FEBS Letters 580 (2006) 5807–5814signiﬁcantly reduced the binding of tubulin to the TPPP/p25
aﬃnity column (data not shown), although their association
has been extensively demonstrated in various alive cells [2,5].
A plausible interpretation of ﬁndings could be the crowding ef-
fect in vivo, which is known to signiﬁcantly increase the hetero-
associations of proteins [16].3.2. Interaction of TPPP/p25 and GAPDH is direct
ELISA was used to test whether the interaction between
TPPP/p25 and GAPDH is direct, and whether it occurs at
physiological conditions concerning the concentration of
NAD+ and salt. For this purpose the following ELISA exper-
iments were performed. Rabbit muscle GAPDH, with and
without NAD+, in absence and in the presence of physiological
salt concentrations was immobilized on the plate and various
concentrations of TPPP/p25 were added to the wells. TPPP/
p25 bound to GAPDH was detected by the addition of anti-
TPPP/p25 antiserum as primary antibody (cf. Section 2). As
shown in Fig. 3, the two isolated proteins interact with each
other in a concentration dependent manner; however, the
interaction is practically resistant against the eﬀects of
NAD+ and salt concentrations. (The experimental curve mea-
sured at low ionic strength does not reach saturation probably
due to unspeciﬁc binding.) The results obtained with puriﬁed
proteins are apparently in disagreement with the ﬁnding eval-
uated from experiments with brain extract. However, taking
into account the signiﬁcant diﬀerence in the complexity of
the two systems, one can suggest that the nature of the interac-
tion, the interacting forces are diﬀerent. This diﬀerence could
be due to indirect, piggy back binding of GAPDH, or GAPDH
displays multiple interactions with TPPP/p25 and other tar-
gets.Fig. 5. Immunohistochemistry (A, B) and double immunolabelling for GA
a-synuclein (red) (D) in the substantia nigra from a patient with Parkinson’
addition, in the left corner of (D), fragments of Lewy neurites are also show3.3. Co-localization of GAPDH with TPPP/p25 in
aggresome-like aggregate of HeLa cells
In order to get information whether the interaction of TPPP/
p25 with GAPDH occurs under intracellular conditions, we
studied the co-localization of these proteins. EGFP-TPPP/
p25 was expressed in HeLa cells, and the localization of the
green ﬂuorescent fusion protein and the immunostained
endogenous GAPDH were visualized by epiﬂuorescence
microscopy. The untransfected cells (no green signal) appeared
as ‘‘red’’ ones due to the immunostaining of endogenous
GAPDH with Texas Red-conjugated secondary antibody. As
we demonstrated previously [5], while the empty EGFP-C1
vector expressed green ﬂuorescent protein distributed homog-
enously within the cell; EGFP-TPPP/p25, at low expression le-
vel, was aligned along the microtubular network in HeLa cells
[5]. Under this condition GAPDH did not show co-localiza-
tion with the TPPP/p25-decorated microtubule system, it dis-
tributed homogeneously within the cytosol similarly to that
of untransfected cells (Fig. 4A–C). High expression of
EGFP-TPPP/p25 resulted in signiﬁcant ultrastructural altera-
tions of the microtubular network with concomitant appear-
ance of a protein aggregate (aggresome-like body) around
the centrosome [5]. In these cells GAPDH did not display uni-
form distribution in the cytosol, but it co-localized with TPPP/
p25, which are extensively enriched within the protein aggre-
gates (see orange cell in the merged image, Fig. 4F). To obtain
quantitative data for the overlap of TPPP/p25 and GAPDH
we counted the transfected cells which contain aggresome-like
bodies at high TPPP/p25 expression level. The GAPDH was
enriched in 10–15% of the aggresomes.
To clarify if the cells forming aggresome-like structure by
overexpression of TPPP/p25 execute apoptotic death, DAPI
staining was performed (cf. Fig. 4). Rather interestingly, nei-PDH (red) and a-synuclein (green) (C), and TPPP/p25 (green) and
s disease. All images show a neuronal intracytoplasmic Lewy-body. In
n. Bar represents 10 lm in A and B, and 20 lm in C and D.
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tation was visualized, which suggested that TPPP/p25 over-
expression did not induce apoptosis. The polarization state
of the mitochondrial membrane related to the energy metabo-
lism of living cell was investigated by TMRE, a ﬂuorescent dye
which stains exclusively the hyperpolarized mitochondrial
membrane [17]. As shown in Fig. 4G–I in the case of the
untransfected cells and of those expressing TPPP/p25 at low
level, the mitochondrial membrane appeared to be hyperpolar-
ized. However, at high expression level of EGFP-TPPP/p25,
when aggresome-like body was formed, red ﬂuorescence is vir-
tually undetectable. This indicates that the mitochondrial
membrane potential is collapsed resulting in the depletion of
both cytosolic and mitochondrial NAD+ pools by opening per-
meability transition pore [18]. Therefore, non-physiological
situation may favour the co-accumulation of TPPP/p25 and
GAPDH within the aggresome-like body. This situation prob-
ably mimics pathological circumstances, when the accumula-
tion of proteins occurs at speciﬁc microenvironment.3.4. Co-localization of TPPP/p25 and GAPDH in human
pathological brain
The co-localization of TPPP/p25 and GAPDH was tested
under pathological conditions in human brain tissues. Previ-
ously we reported the extensive co-localization of TPPP/p25
with a-synuclein and their enrichment in inclusions character-
istic for a-synucleinopathies including LBs of post-mortem PD
brain [6]. Immunostaining for a-synuclein as well as for TPPP/
p25 revealed numerous typical intra- and extracellular LBs and
Lewy neurites throughout the substantia nigra and less in the
dorsal raphe (data not shown). Herein, we tested the localiza-
tion of GAPDH within LBs in nigral sections of PD.
Fig. 5 shows the immunohistochemical studies by using anti-
bodies against TPPP/p25, a-synuclein and GAPDH. Almost
complete co-localization of TPPP/p25 with a-synuclein can
be visualized within LBs in agreement with our previous data
where 90% co-localization was quantiﬁed [6]. In contrast,
GAPDH immunoreactivity can be seen only in the rim of typ-
ical compact LBs (Fig. 5A and B), thus its co-localization with
a-synuclein (Fig. 5C) is focal. This ﬁnding qualitatively corre-
sponds to a recent data where about 20% co-localization of
a-synuclein with GAPDH was observed in inclusions of
PD [8,19].
3.5. Conclusion
Recent in vitro and in vivo data have shown that the primary
target of TPPP/p25 is the tubulin/microtubule, and its physio-
logical function is likely the stabilization of the microtubular
system, which is fulﬁlled via its bundling activity [20]. The inter-
action of TPPP/p25 with a-synuclein, a marker of PD and other
synucleinopathies, was demonstrated as well [21]. Our present
data suggest that TPPP/p25 interacts with GAPDH, however,
the nature and strength of this interaction depend on the pres-
ence of other proteins, which can form protein complexes with
GAPDH or just function as crowding agents, and on the micro-
environment such as local ionic strength or NAD+ concentra-
tion. In fact, the eﬀect of NAD+ on the multiple interactions
of GAPDH has been reported suggesting the role of NAD+
binding site in its non-glycolytic function [9]. Extreme circum-
stances could occur within an aggresome-like body and LB.
Our present data suggest that these conditions favour theassemblies of TPPP/p25, a-synuclein and GAPDH (cf. Figs. 4
and 5). The state of our knowledge with respect to the intra-
inclusional situation is still in its infancy. It may be accurate
to say that the post-translational modiﬁcations of proteins play
a role in the neurodegenerative process. Thus, for example,
GAPDH was found to be an excessively nitrated protein in
AD hippocampus [22], or phosphorylated in postsynaptic den-
sity [23]. These modiﬁcations result in inactivation or diﬀerent
associative capability of GAPDH (for review see [9]). It is worth
noting that apart from GAPDH, elongation factor 1 alpha and
TPPP/p25 were found as well in postsynaptic densities [23,24].
The knowledge of these molecular interactions through which
cells regulate intracellular localization and function as well as
formation of pathological entities is crucial, because such fac-
tors would clarify not only the genesis of LBs but could also
provide clues about the therapeutic targets in PD and other
synucleinopathies.
Acknowledgements: This work was supported by Hungarian National
Scientiﬁc Research Fund Grants OTKA T-046071 to J. Ova´di and
T-049247 to F.O.; FP6-2003-LIFESCIHEALTH-I: Bio-Sim, NKFP-
MediChem2 1/A/005/2004 to J. Ova´di.References
[1] Hlavanda, E., Kova´cs, J., Ola´h, J., Orosz, F., Medzihradszky,
K.F. and Ova´di, J. (2002) Brain-speciﬁc p25 protein binds to
tubulin and microtubules and induces aberrant microtubule
assemblies at substoichiometric concentrations. Biochemistry 41,
8657–8664.
[2] Tiria´n, L. et al. (2003) TPPP/p25 promotes tubulin assemblies
and blocks mitotic spindle formation. Proc. Natl. Acad. Sci. USA
100, 13976–13981.
[3] Seki, N., Hattori, A., Sugano, S., Suzuki, Y., Nakagawara, A.,
Muramatsu, M., Hori, T. and Saito, T. (1999) A novel human
gene whose product shares signiﬁcant homology with the bovine
brain-speciﬁc protein p25 on chromosome 5p15.3. J. Hum. Genet.
44, 121–122.
[4] Orosz, F., Kova´cs, G.G., Lehotzky, A., Ola´h, J., Vincze, O. and
Ova´di, J. (2004) TPPP/p25: from unfolded protein to misfolding
disease: prediction and experiments. Biol. Cell 96, 701–711.
[5] Lehotzky, A., Tiria´n, L., Tokesi, N., Lenart, P., Szabo´, B.,
Kova´cs, J. and Ova´di, J. (2004) Dynamic targeting of microtu-
bules by TPPP/p25 aﬀects cell survival. J. Cell Sci. 117, 6249–
6259.
[6] Kova´cs, G.G. et al. (2004) Natively unfolded tubulin polymer-
ization promoting protein TPPP/p25 is a common marker of
alpha-synucleinopathies. Neurobiol. Dis. 17, 155–162.
[7] Ova´di, J., Orosz, F. and Holla´n, S. (2004) Functional aspects of
cellular microcompartmentation in the development of neurode-
generation: mutation induced aberrant protein-protein associa-
tions. Mol. Cell. Biochem. 256–257, 83–93.
[8] Tsuchiya, K. et al. (2005) Pro-apoptotic protein glyceraldehyde-
3-phosphate dehydrogenase promotes the formation of Lewy
body-like inclusions. Eur. J. Neurosci. 21, 317–326.
[9] Sirover, M.A. (1999) New insights into an old protein: the
functional diversity of mammalian glyceraldehyde-3-phosphate
dehydrogenase. Biochim. Biophys. Acta 1432, 159–184.
[10] Li, K.W. et al. (2004) Proteomics analysis of rat brain postsyn-
aptic density. Implications of the diverse protein functional
groups for the integration of synaptic physiology. J. Biol. Chem.
279, 987–1002.
[11] Jordan, B.A., Fernholz, B.D., Boussac, M., Xu, C., Grigorean,
G., Ziﬀ, E.B. and Neubert, T.A. (2004) Identiﬁcation and
veriﬁcation of novel rodent postsynaptic density proteins. Mol.
Cell. Proteomic. 3, 857–871.
[12] Conway, A. and Koshland, D.E.J. (1968) Negative cooperativity
in enzyme action. The binding of diphosphopyridine nucleotide to
glyceraldehyde 3-phosphate dehydrogenase. Biochemistry 7,
4011–4023.
5814 J. Ola´h et al. / FEBS Letters 580 (2006) 5807–5814[13] Shen, Y.-Q., Li, J., Song, S.-Y. and Lin, Z.-J. (2000) Structure of
Apo-glyceraldehyde-3-phosphate Dehydrogenase from Palinurus
versicolor. J. Struct. Biol. 130, 1–9.
[14] Liliom, K., Wa´gner, G., Kova´cs, J., Comin, B., Cascante, M.,
Orosz, F. and Ova´di, J. (1999) Combined enhancement of
microtubule assembly and glucose metabolism in neuronal
systems in vitro. Decreased sensitivity to copper toxicity. Bio-
chem. Biophys. Res. Commun. 264, 605–610.
[15] Iijima, T., Mishima, T., Akagawa, K. and Iwao, Y. (2003)
Mitochondrial hyperpolarization after transient oxygen–glucose
deprivation and subsequent apoptosis in cultured rat hippocam-
pal neurons. Brain Res. 993, 140–145.
[16] Minton, A. (2001) The inﬂuence of macromolecular crowding and
macromolecular conﬁnement on biochemical reactions in physi-
ological media. J. Biol. Chem. 276, 10577–10580.
[17] Collins, T.J. and Bootman, M.D. (2003) Mitochondria are
morphologically heterogeneous within cells. J. Exp. Biol. 206,
1993–2000.
[18] Di Lisa, F., Menabo, R., Canton, M., Barile, M. and Bernardi, P.
(2001) Opening of the mitochondrial permeability transition pore
causes depletion of mitochondrial and cytosolic NAD+ and is a
causative event in the death of myocytes in postischemic reper-
fusion of the heart. J. Biol. Chem. 276, 2571–2575.[19] Tatton, N.A. (2000) Increased caspase 3 and Bax immunoreac-
tivity accompany nuclear GAPDH translocation and neuronal
apoptosis in Parkinson’s disease. Exp. Neurol. 166, 29–43.
[20] Ova´di, J., Orosz, F. and Lehotzky, A. (2005) What is the
biological signiﬁcance of the brain-speciﬁc tubulin-polymerization
promoting protein (TPPP/p25)? IUBMB Life 57, 765–768.
[21] Lindersson, E. et al. (2005) p25alpha stimulates alpha-synuclein
aggregation and is co-localized with aggregated alpha-synuclein in
alpha-synucleinopathies. J. Biol. Chem. 280, 5703–5715.
[22] Sultana, R., Poon, H.F., Cai, J., Pierce, W.M., Merchant, M.,
Klein, J.B., Markesbery, W.R. and Butterﬁeld, D.A. (2006)
Identiﬁcation of nitrated proteins in Alzheimer’s disease brain
using a redox proteomics approach. Neurobiol. Dis. 22, 76–87.
[23] Wu, K., Aoki, C., Elste, A., Rogalski-Wilk, A. and Siekevitz, P.
(1997) The synthesis of ATP by glycolytic enzymes in the
postsynaptic density and the eﬀect of endogenously generated
nitric oxide. Proc. Natl. Acad. Sci. USA 94, 13273–13278.
[24] Walsh, M.J. and Kuruc, N. (1992) The postsynaptic density:
constituent and associated proteins characterized by electropho-
resis, immunoblotting, and peptide sequencing. J. Neurochem. 59,
667–678.
[25] Biemann, K. (1990) Nomenclature for peptide fragment ions.
Meth. Enzymol. 193, 886–887.
